MarketPulse

nicotine pouches

5 articles
The Motley FoolThe Motley Fool··Brett Schafer

FDA Caution on Nicotine Pouches Sends Turning Point Brands Stock Plummeting 15.5%

$TPB stock plunged 15.5% as FDA hesitation on nicotine pouch approvals threatens Fre brand growth, which rose 266% YoY but now faces regulatory headwinds.
TPBFDA approvalTurning Point Brands
The Motley FoolThe Motley Fool··Eric Volkman

FDA Safety Concerns Crush Turning Point Brands Stock 14% on Nicotine Pouch Risks

Turning Point Brands stock drops 14% after FDA scientists express safety concerns about nicotine pouches, threatening approval of key products.
TPBregulatory riskFDA approval
The Motley FoolThe Motley Fool··James Brumley

Altria's Nationwide Nicotine Pouch Push: Dividend Play Over Growth Story

Altria expands oral nicotine pouch brand 'on!' nationwide following FDA approval, though growth remains limited as product mainly displaces traditional oral tobacco. The 6.7% dividend yield appeals to income investors.
MOdividend yieldretail expansion
The Motley FoolThe Motley Fool··Jeremy Bowman

Altria Gains as Investors Flee to Safety, Launches Nicotine Pouch Expansion

Altria stock rose 2.82% as risk-averse investors sought dividend yields amid market turbulence and geopolitical tensions, while company announced nicotine pouch rollout.
XLPMOBTIPMmarket rotationdividend stocks
The Motley FoolThe Motley Fool··Brett Schafer

Turning Point Brands Stock Crashes 33% as Earnings Miss, Guidance Slashed

$TPB plunged 33% after missing Q4 earnings and slashing 2026 guidance. Nicotine pouch business surges 266% YoY but heavy investments compress margins significantly.
TPBearnings missvaluation